Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Infusion for Chronic Debilitating Migraines
NCT07061847Phase 2Recruiting
- Sponsor
- Northwell Health
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine in chronic migraine, sponsored by Northwell Health. Started Mar 2025; status: recruiting.
02
Drugs
lidocaine
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT07061847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07061847.